Central and Peripheral Distribution of Bone Marrow on Bone Marrow Scintigraphy with Antigranulocytic Antibody in Hematologic Malignancy |
Kang, Do-Young
(Department of Nuclear Medicine, Dong-A University College of Medicine)
Lee, Jae-Tae (Department of Nuclear Medicines, Kyungpook University School of Medicine) Sohn, Sang-Kyun (Department of Nuclear Medicines, Kyungpook University School of Medicine) Lee, Kyu-Bo (Department of Nuclear Medicines, Kyungpook University School of Medicine) |
1 | Jakubowski A, Scheinberg DA. Noninvasiveevaluation of the bone marrow (editorial). J NuclMed 1996;37:982-4. |
2 | Sayle BA, Helmer RE, Birdsong BA, BalachandranS, Gardner PH. Bone-marrow imaging with indium-Ill chloride in aplastic anemia and myelofibrosis: concise communication. J Nucl Med 1982;23: 121-5. |
3 | Lee KH, Chung JK, Choi CH, Jeong JM, LeeDS, Bang YJ, et al. Technetium-99m-labeledantigranulocyte antibody bone marrow scintigraphy.J Nucl Med 1995;36:1800-5. |
4 | Kim DH, Lee J, Baek JH, Jung JT, Hyun DW,Chun KA, et al. Bone marrow scintigraphy withanti granulocyte antibody in multiple myeloma:comparison with simple radiography and bonescintigraphy. Korean J Nucl Med 1998;32:354-64. |
5 | Reske SN. Recent advances in bone marrowscanning. Eur J Nucl Med 1991;18:203-21. |
6 | Hoppin EC, Lewis JP, Denardo SJ. Bonemarrow scintigraphy in the evaluation of acutenonlymphocytic leukemia. Clin Nucl Med 1979;7:296-301. |
7 | Huic D, Ivancevic V, Richter WS, Munz DL.Immunoscintigraphy of the bone marrow: normaluptake values of technetium-99m-Iabeled monoclonalantigranulocyte antibodies. J Nucl Med1997;38: 1755-8. |
8 | Kuroki M, Koga Y, Matsuoka Y. Monoclonalantibodies to carcinoembryonic antigen: a systemicanalysis of antibody specificities by usingrelated normal antigrdens and evidence for allotypicdeterminants on carcinoembryonic antigen.J Immunol 1984;133:2090-7. |
9 | Buchegger F, Schreyer M, Carral S. Monoclonalantibodies identify a CEA cross-reacting antigenof 95 kDa (NCA-95) distinct in antigenicity andtissue distribution from the previously describedNCA of 55 kDa. Int J Cancer 1984;33:839-45. |
10 | Chung JK, Yeo J, Lee DS, Park S, Lee MC,Kim BK, et al. Bone marrow scintigraphy usingtechnetium-99m antigranulocyte antibody inhematologic disorders. J Nucl Med 1996;37:978-82. |
11 | Cho JH, Kim MJ, Lee JD, Park CY, Kim KY.Evaluation of bone marrow involvement inleukemic patients using bone marrow scan.Korean J Nucl Med 1993;27:298-304. |
12 | Byfield JE, Klisak I, Bennett LR. Thermalmarrow expansion: effect of temperature onbone marrow distribution. Int J Radiation OncologyBioi Phys 1984;10:875-83. |
13 | Duncker CM, Carrio I, Bema L, Estorch M,Alonso C, Oheda B, et al. Radioimmuneimaging of bone marrow in patients withsuspected bone metastases from primary breastcancer. J Nucl Med 1990;31:1450-5. |
14 | Lee YH, Lee J, Paik JH, Kim DH, Chung JT,Chun KA, et al. Scintigraphic evaluation ofhematologic diseases with Tc-99m labeledantigranulocyte antibody. Korean J Hematol1998;33:206-14. |
15 | Moore SG, Dawson KL. Red and yellowmarrow in the femur: age-related changes inappearance at MR imaging. Radiology 1990;175:219-23. |
16 | Agren B, Rudberg U, Mare K, Aspelin P. Bonemarrow imaging of bone marrow transplantedmultiple myeloma patients. Clin Nucl Med1997;22:80-92. |
17 | Najean Y, Danvic ML, Mercier NL, Pecking A,Colonna P, Rain JD. Significance of bonemarrowscintigraphy in aplastic anemia: concisecommunication. J Nucl Med 1980;21:213-8. |
18 | Munz DL. Bone marrow scanning. principles,clinical results and indications. Radiologe 1992;32:485-94. |